MARINE PETROLEUM TRUST (MARPS)

US5684231070

4.1501  -0.05 (-1.25%)

Fundamental Rating

5

Overall MARPS gets a fundamental rating of 5 out of 10. We evaluated MARPS against 214 industry peers in the Oil, Gas & Consumable Fuels industry. MARPS scores excellent on profitability, but there are some minor concerns on its financial health. MARPS has a valuation in line with the averages, but it does not seem to be growing.



Quickly go to:

8

1. Profitability

1.1 Basic Checks

MARPS had positive earnings in the past year.
MARPS had a positive operating cash flow in the past year.
MARPS had positive earnings in each of the past 5 years.
Each year in the past 5 years MARPS had a positive operating cash flow.

1.2 Ratios

The Return On Assets of MARPS (91.43%) is better than 96.26% of its industry peers.
MARPS has a better Return On Equity (91.43%) than 92.99% of its industry peers.
With an excellent Return On Invested Capital value of 72.23%, MARPS belongs to the best of the industry, outperforming 96.73% of the companies in the same industry.
MARPS had an Average Return On Invested Capital over the past 3 years of 69.24%. This is significantly above the industry average of 44.55%.
The 3 year average ROIC (69.24%) for MARPS is below the current ROIC(72.23%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 91.43%
ROE 91.43%
ROIC 72.23%
ROA(3y)87.65%
ROA(5y)77.71%
ROE(3y)87.65%
ROE(5y)77.71%
ROIC(3y)69.24%
ROIC(5y)61.39%

1.3 Margins

The Profit Margin of MARPS (77.52%) is better than 92.06% of its industry peers.
MARPS's Profit Margin has improved in the last couple of years.
MARPS has a better Operating Margin (77.52%) than 94.39% of its industry peers.
In the last couple of years the Operating Margin of MARPS has grown nicely.
Industry RankSector Rank
OM 77.52%
PM (TTM) 77.52%
GM N/A
OM growth 3Y5.05%
OM growth 5Y1.97%
PM growth 3Y5.05%
PM growth 5Y1.97%
GM growth 3YN/A
GM growth 5YN/A

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, MARPS has about the same amount of shares outstanding.
The number of shares outstanding for MARPS remains at a similar level compared to 5 years ago.
MARPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MARPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

2

3. Growth

3.1 Past

The earnings per share for MARPS have decreased strongly by -47.72% in the last year.
MARPS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.90% yearly.
MARPS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -40.76%.
The Revenue has been growing by 13.66% on average over the past years. This is quite good.
EPS 1Y (TTM)-47.72%
EPS 3Y33.5%
EPS 5Y15.9%
EPS growth Q2Q-47.57%
Revenue 1Y (TTM)-40.76%
Revenue growth 3Y27.83%
Revenue growth 5Y13.66%
Revenue growth Q2Q-40.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.22, which indicates a very decent valuation of MARPS.
MARPS's Price/Earnings ratio is a bit cheaper when compared to the industry. MARPS is cheaper than 61.22% of the companies in the same industry.
When comparing the Price/Earnings ratio of MARPS to the average of the S&P500 Index (28.28), we can say MARPS is valued rather cheaply.
Industry RankSector Rank
PE 9.22
Fwd PE N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MARPS is valued a bit cheaper than the industry average as 67.76% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.15
EV/EBITDA N/A

4.3 Compensation for Growth

The excellent profitability rating of MARPS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.58
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.01%, MARPS is a good candidate for dividend investing.
MARPS's Dividend Yield is rather good when compared to the industry average which is at 5.78. MARPS pays more dividend than 89.25% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, MARPS pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.01%

5.2 History

The dividend of MARPS is nicely growing with an annual growth rate of 17.57%!
MARPS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)17.57%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

104.59% of the earnings are spent on dividend by MARPS. This is not a sustainable payout ratio.
The dividend of MARPS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP104.59%
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

MARINE PETROLEUM TRUST

NASDAQ:MARPS (5/3/2024, 7:04:47 PM)

4.1501

-0.05 (-1.25%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.30M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 10.01%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 9.22
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.58
Profitability
Industry RankSector Rank
ROA 91.43%
ROE 91.43%
ROCE
ROIC
ROICexc
ROICexgc
OM 77.52%
PM (TTM) 77.52%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-47.72%
EPS 3Y33.5%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-40.76%
Revenue growth 3Y27.83%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y